Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Airway MedixWAR:AWM +1.12%17 EV-to-EBITDA is 12.05 as of Aug. 17, 2026. GuruFocus rates WAR:AWM with a GF Score™ of 17/100. The stock has 9 warning signs investors should review. Among 513 Medical Devices & Instruments companies, Airway Medix ranks better than 59.84% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Airway Medix's enterprise value is zł39.45 Mil.
Airway Medix's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was zł3.27 Mil. Therefore, Airway Medix's EV-to-EBITDA for today is 12.05.
The historical rank and industry rank for Airway Medix's EV-to-EBITDA or its related term are showing as below:
WAR:AWM'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -275.1 Med: -0.96 Max: 1027.44
Current: 12.05
During the past 12 years, the highest EV-to-EBITDA of Airway Medix was 1027.44. The lowest was -275.10. And the median was -0.96.
WAR:AWM's EV-to-EBITDA is ranked better than 59.84% of 513
companies
in the Medical Devices & Instruments industry
Industry Median: 14.95
vs WAR:AWM: 12.05
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Airway Medix's PE Ratio (TTM) for today is calculated as:
Airway Medix's share price for today is zł0.272.
Airway Medix's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł0.020.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Airway Medix's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WAR:AWM vs ISRG, BDX, MDLN: EV-to-EBITDA Comparison
For the Medical Instruments & Supplies subindustry, Airway Medix's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Airway Medix EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Airway Medix's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Airway Medix's EV-to-EBITDA falls into.
Airway Medix's current Enterprise Value is zł39.45 Mil.
Airway Medix's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł3.27 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Airway Medix (WAR:AWM) has a EV-to-EBITDA of 12.05 as of Aug. 17, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Airway Medix. According to the industry distribution chart, Airway Medix ranks #206 out of 513 companies in the Medical Devices & Instruments industry, placing it in the top 40.2%.
Is Airway Medix's EV-to-EBITDA too high?
Airway Medix's current EV-to-EBITDA is 12.05. The Medical Devices & Instruments industry median EV-to-EBITDA is 14.95. Airway Medix's value of 12.05 is 19.4% below this industry median. Based on the distribution chart, Airway Medix ranks #206 out of 513 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Airway Medix has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Airway Medix's EV-to-EBITDA compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Airway Medix ranks #206 out of 513 companies for EV-to-EBITDA. This puts Airway Medix in the upper half of its industry. The industry median EV-to-EBITDA is 14.95. Airway Medix's value of 12.05 is 19.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.95, based on 513 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Airway Medix's current EV-to-EBITDA of 12.05 is 19.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Airway Medix. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Airway Medix's current EV-to-EBITDA is 12.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Airway Medix stock overvalued right now?
Airway Medix (WAR:AWM) has a current EV-to-EBITDA of 12.05. The current EV-to-EBITDA is 12.05 and 19.4% below the Medical Devices & Instruments industry median of 14.95. Airway Medix's overall GF Score™ is 17/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Airway Medix (WAR:AWM), the current EV-to-EBITDA is 12.05 as of Aug. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Airway Medix SA focuses on research, development, and commercialization of devices for single use in mechanically ventilated patients at Intensive Care Units as well as in patients with life-threatening and anaesthesiologic wards. The company's products include the Closed Suction System, the Oral Care System, and the Cuff Pressure Regulator.
17GF Score
Get the complete analysis for WAR:AWM
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:AWM has been successfully added to your 
